SEC Filings | Calithera Biosciences, Inc.

SEC Filings

Filing date	Form	Description	Filing Group	View
03/31/23	10-K	Annual report which provides a comprehensive overview of the company for the past year	Annual Filings	0000950170-23-011047.pdf 0000950170-23-011047.rtf 0000950170-23-011047.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
03/17/23	EFFECT	EFFECT	Other	9999999995-23-000597.pdf 9999999995-23-000597.rtf 9999999995-23-000597.xls View HTML
03/14/23	POS AM	Post-effective amendment to an S-Type filing	Registration Statements	0001193125-23-070124.pdf 0001193125-23-070124.rtf 0001193125-23-070124.xls View HTML
03/14/23	S-8 POS	Post-effective amendment to an S-8 filing	Registration Statements	0001193125-23-070129.pdf 0001193125-23-070129.rtf View HTML
03/14/23	S-8 POS	Post-effective amendment to an S-8 filing	Registration Statements	0001193125-23-070138.pdf 0001193125-23-070138.rtf View HTML
03/14/23	S-8 POS	Post-effective amendment to an S-8 filing	Registration Statements	0001193125-23-070142.pdf 0001193125-23-070142.rtf View HTML
03/14/23	S-8 POS	Post-effective amendment to an S-8 filing	Registration Statements	0001193125-23-070136.pdf 0001193125-23-070136.rtf View HTML
03/14/23	S-8 POS	Post-effective amendment to an S-8 filing	Registration Statements	0001193125-23-070145.pdf 0001193125-23-070145.rtf View HTML
03/14/23	S-8 POS	Post-effective amendment to an S-8 filing	Registration Statements	0001193125-23-070147.pdf 0001193125-23-070147.rtf View HTML
03/14/23	S-8 POS	Post-effective amendment to an S-8 filing	Registration Statements	0001193125-23-070150.pdf 0001193125-23-070150.rtf View HTML

Data provided by Kaleidoscope.

Investor & Media Contact

Stephanie Wong
Chief Financial Officer

1.650.870.1063
ir@Calithera.com

Investor Tools